NCT02265640View on ClinicalTrials.gov

Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

December 31, 2000

Conditions
Healthy
Interventions
DRUG

BIIL 284 BS boli

DRUG

BIIL 284 BS tablet C

OTHER

standard breakfast

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY